EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, InfuSystems Holdings's enterprise value is $195.4 Mil.
InfuSystems Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $16.5 Mil. Therefore, InfuSystems Holdings's EV-to-EBITDA for today is 11.82.
The historical rank and industry rank for InfuSystems Holdings's EV-to-EBITDA or its related term are showing as below:
INFU'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.25 Med: 15.83 Max: 55.98
Current: 11.82
During the past 13 years, the highest EV-to-EBITDA of InfuSystems Holdings was 55.98. The lowest was 7.25. And the median was 15.83.
INFU's EV-to-EBITDA is ranked better than 60.25% of 483
companies
in the Medical Devices & Instruments industry
Industry Median: 16.52
vs INFU: 11.82
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
InfuSystems Holdings EV-to-EBITDA Historical Data
The historical data trend for InfuSystems Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of InfuSystems Holdings's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's EV-to-EBITDA falls into.
InfuSystems Holdings's current Enterprise Value is $195.4 Mil.
InfuSystems Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
InfuSystems Holdings's PE Ratio for today is calculated as:
InfuSystems Holdings's share price for today is $7.28.
InfuSystems Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.033.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of InfuSystems Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
InfuSystems Holdings (InfuSystems Holdings) Business Description
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INFU has been successfully added to your 